This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Arvind Kumar Singla: Innovator in Immunosuppressive Agents
Introduction
Arvind Kumar Singla is a notable inventor based in Chandigarh, India. He has made significant contributions to the field of immunology through his innovative research and development of bioactive compounds. His work focuses on the use of specific compounds as immunosuppressive agents, which can have profound implications for medical treatments.
Latest Patents
Singla holds a patent for the use of bipyridine compound 'Caerulomycin A' derivatives and analogs as immunosuppressive agents. The patent describes an isolated bioactive molecule, Caerulomycin A, which has shown effectiveness in targeting lymphocytes, including CD4T cells, CD8T cells, and B cells. The compound operates by downregulating the expression of the activation marker CD28 while upregulating the immunosuppressive marker CTLA-4. This innovative approach highlights the compound's potential in modulating immune responses, particularly in the production of IL-4, IFN-γ, and antibodies. Notably, while Caerulomycin A has been recognized for its antifungal activity, its immunomodulatory properties were previously unexplored.
Career Highlights
Arvind Kumar Singla is affiliated with the Council of Scientific and Industrial Research, where he continues to advance his research in immunology. His dedication to scientific inquiry and innovation has positioned him as a key figure in the development of new therapeutic agents.
Collaborations
Singla has collaborated with esteemed colleagues, including Javed Naim Agrewala and Rakesh Mulraj Vohra. These partnerships have fostered a collaborative environment that enhances the research and development of immunosuppressive agents.
Conclusion
Arvind Kumar Singla's contributions to the field of immunology through his patent on Caerulomycin A derivatives exemplify the importance of innovation in medical science. His work not only advances our understanding of immunosuppressive agents but also opens new avenues for therapeutic applications.